Abstract Background Previous studies on the role of TP53 mutation in breast cancer treatment response and survival are contradictory and inconclusive. limited by the use of different endpoints to determine clinical significance and by small sample sizes that prohibit stratification by treatment. Methods We utilized large datasets to examine overall survival according to TP53 mutation ... https://www.houseandholders.shop/product-category/jar/